More $KTOV DD: Latest $KTOV filing announcing phase 1/2 initiation. While it’s not the collab everyone wanted to be announced, it definitely does make it seem like a collab will be announced at eventually. Announces phase 1/2 uses Cetuximab, you guessed it, a Merck drug $MRK. 👀 https://t.co/0AVJzdApqs